We are live on ! Find out more
AGTC

Applied Genetic Technologies Corporation
AGTC

Delisted

AGTC was delisted on the 30th of November, 2022.

Back to rankings

64 hedge funds and large institutions have $32.6M invested in Applied Genetic Technologies Corporation in 2018 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 4

19% more funds holding

Funds holding: 54 → 64 (+10)

4% more capital invested

Capital invested by funds: $31.4M → $32.6M (+$1.22M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 18

Holders
64
Holders Change
+10
Holders Change %
+18.52%
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
18
Reduced
18
Closed
4
Calls
$90K
Puts
–
Net Calls
+$90K
Net Calls Change
+$4K

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$1.22M
2
Renaissance Technologies
Renaissance Technologies
New York
+$651K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$460K
4
ASP
Adams Street Partners
Illinois
+$332K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$323K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$676K
2
Man Group
Man Group
United Kingdom
-$402K
3
MERSOM
Municipal Employees' Retirement System of Michigan
Michigan
-$331K
4
BlackRock
BlackRock
New York
-$237K
5
PAM
Panagora Asset Management
Massachusetts
-$198K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$223K +$278K +60,142 New
Russell Investments Group
27
Russell Investments Group
United Kingdom
$220K -$11.4K -2,473 -4%
Bank of America
28
Bank of America
North Carolina
$181K +$18K +3,885 +9%
Morgan Stanley
29
Morgan Stanley
New York
$165K -$7.99K -1,727 -4%
PAM
30
Panagora Asset Management
Massachusetts
$146K -$198K -42,806 -52%
BFM
31
Boothbay Fund Management
New York
$144K +$180K +38,968 New
Fidelity Investments
32
Fidelity Investments
Massachusetts
$133K -$676K -146,198 -80%
MAM
33
Marquette Asset Management
Minnesota
$129K +$161K +34,845 New
Two Sigma Investments
34
Two Sigma Investments
New York
$120K +$150K +32,492 New
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
$119K +$82.2K +17,758 +124%
MCM
36
Matarin Capital Management
New York
$102K -$24.4K -5,272 -16%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$99K +$62.1K +13,419 +101%
FDCDDQ
38
Federation des caisses Desjardins du Quebec
Quebec, Canada
$97.5K – – –
HP
39
Harbourvest Partners
Massachusetts
$86K +$108K +23,356 New
Canada Pension Plan Investment Board
40
Canada Pension Plan Investment Board
Ontario, Canada
$81K +$102K +22,000 New
Aberdeen Group
41
Aberdeen Group
United Kingdom
$80K +$99.5K +21,498 New
Millennium Management
42
Millennium Management
New York
$79K -$59.8K -12,925 -38%
Northern Trust
43
Northern Trust
Illinois
$77K – – –
TRCT
44
Tower Research Capital (TRC)
New York
$73K +$85.2K +18,406 +1,184%
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$67K – – –
Two Sigma Advisers
46
Two Sigma Advisers
New York
$66K +$2.31K +500 +3%
PP
47
PDT Partners
New York
$61K – – –
JP Morgan Chase
48
JP Morgan Chase
New York
$58K +$72K +15,570 New
Tudor Investment Corp
49
Tudor Investment Corp
Connecticut
$55K – – –
Macquarie Group
50
Macquarie Group
Australia
$55K +$21.7K +4,700 +47%
1
2
3

AGTC Hedge Fund Activity: Q2 2018 in Review

64 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q2 2018, worth a combined $32.6M — up 3.9% from $31.4M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new AGTC positions and 4 closed out — a net gain of 10 holders — while 18 added to existing stakes and 18 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $1.22M. The largest seller was Fidelity Investments, cutting an estimated $676K.

  • 64 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q2 2018, up from 54 in Q1 2018.
  • Funds reported $32.6M of Applied Genetic Technologies Corporation stock for Q2 2018, up 3.9% quarter-over-quarter.
  • 14 funds opened new Applied Genetic Technologies Corporation positions in Q2 2018 and 4 closed out, a net change of +10 holders.
  • The largest Applied Genetic Technologies Corporation buyer in Q2 2018 was T. Rowe Price Associates, an estimated $1.22M added.
  • The largest Applied Genetic Technologies Corporation seller in Q2 2018 was Fidelity Investments, an estimated $676K sold.

Based on aggregated 13F filings for Q2 2018.